Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
Momenta Pharmaceuticals Announces CAFC Decision to Invalidate Remanded Teva Pharmaceuticals Patent in Daily COPAXONE(R) 20 mg Suit
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
Design and screening of a glial cell-specific, cell penetrating Peptide for therapeutic applications in multiple sclerosis.
Vitamin D: a natural inhibitor of multiple sclerosis.
De novo PMP2 mutations in families with type 1 Charcot-Marie-Tooth disease.
Natalizumab in the treatment of rheumatoid arthritis in subjects receiving methotrexate
Postmarketing Safety Profile of Subcutaneous Interferon Beta-1a Given 3 Times Weekly: A Retrospective Administrative Claims Analysis.
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
Challenges and recommendations for obtaining chemical structures of industry-provided repurposing candidates.
Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis
Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Ampyra (dalfampridine) medication guide
Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: A meta-analysis of 6977 subjects.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Psoriasis during natalizumab treatment for multiple sclerosis.
Painful Tonic Spasm in Neuromyelitis Optica: Incidence, Diagnostic Utility, and Clinical Characteristics.
Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.

Pages